These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 14712893)

  • 41. [Antiplatelet and anticoagulant treatment after percutaneous transluminal angioplasty for peripheral arteriosclerosis. Survey of a Cochrane review].
    Lorenzen ND; Eldrup N; Laustsen J
    Ugeskr Laeger; 2007 Sep; 169(39):3279-82. PubMed ID: 17953885
    [No Abstract]   [Full Text] [Related]  

  • 42. Antiplatelet pathways development. Panel discussion.
    Ballenger J; Olin JW; Brass LM; Orland BI; Cannon E; Rich SJ; Dresdale A; Stemple C; Moreo K; Zusman R
    Manag Care; 2000 May; 9(5 Suppl):18-24. PubMed ID: 11729409
    [No Abstract]   [Full Text] [Related]  

  • 43. The puzzle of aspirin and sex.
    Levin RI
    N Engl J Med; 2005 Mar; 352(13):1366-8. PubMed ID: 15755763
    [No Abstract]   [Full Text] [Related]  

  • 44. Aspirin resistance: myth or reality?
    Singh S; Kothari SS; Bahl VK
    Indian Heart J; 2003; 55(3):217-22. PubMed ID: 14560929
    [No Abstract]   [Full Text] [Related]  

  • 45. Antiplatelet drugs in secondary prevention of myocardial infarction: clinical recommendations and perspective implications.
    Libretti A; Bertelé V
    J Cardiovasc Pharmacol; 1989; 14 Suppl 9():S89-91. PubMed ID: 2483241
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Prevention of cardiovascular events with antiplatelet drugs: aspirin (and others)?].
    Patrono C
    Minerva Cardioangiol; 1999 Nov; 47(11):389-90. PubMed ID: 10641409
    [No Abstract]   [Full Text] [Related]  

  • 47. Genetic and acquired determinants of individual variability of response to antiplatelet drugs.
    Schafer AI
    Circulation; 2003 Aug; 108(8):910-1. PubMed ID: 12939239
    [No Abstract]   [Full Text] [Related]  

  • 48. An aspirin a day keeps the MI away (for some).
    Miser WF
    Am Fam Physician; 2002 May; 65(10):2000, 2003. PubMed ID: 12046769
    [No Abstract]   [Full Text] [Related]  

  • 49. [Antiplatelet agents and cardiovascular prevention].
    Barry S; Mercier S
    Therapie; 1997; 52(1):53-8. PubMed ID: 9183923
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Aspirin resistance.
    Smout J; Stansby G
    Br J Surg; 2002 Jan; 89(1):4-5. PubMed ID: 11851656
    [No Abstract]   [Full Text] [Related]  

  • 51. The use of antiplatelet agents in cardiac disease.
    Tepper D; Ip RJ; Ip JH
    Manag Care Interface; 2000 May; 13(5):76-8. PubMed ID: 11067401
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Role of platelets and antiplatelet agents in cerebrovascular disease. Clues from trials.
    Harrison MJ
    Circulation; 1990 Jan; 81(1 Suppl):I20-1; discussion I22-3. PubMed ID: 2403864
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Use of antiplatelet drugs in secondary prevention in patients with atherothrombotic disease.
    Aronow WS
    Compr Ther; 2006; 32(3):182-8. PubMed ID: 17435272
    [TBL] [Abstract][Full Text] [Related]  

  • 54. An aspirin a day: are we barking up the wrong willow tree?
    Krantz MJ; Berger JS; Hiatt WR
    Pharmacotherapy; 2010 Feb; 30(2):115-8. PubMed ID: 20099985
    [No Abstract]   [Full Text] [Related]  

  • 55. Preventive cardiology: what is the value of antiplatelet agents and fish oils?
    Lavie CJ; Squires RW; Gau GT
    South Med J; 1988 Sep; 81(9):1145-50. PubMed ID: 3047882
    [No Abstract]   [Full Text] [Related]  

  • 56. Acetylsalicylic acid and vitamin E in prevention of arterial thrombosis.
    Polasek J
    Can J Cardiol; 1997 May; 13(5):533-5. PubMed ID: 9179093
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Prevention in the 21st century. Athero-thrombosis and ischemic events].
    Z Kardiol; 1998 Nov; 87(11 Suppl Atherothro):1-3. PubMed ID: 9883501
    [No Abstract]   [Full Text] [Related]  

  • 58. POPADAD trial. Don't stop taking aspirin.
    Elwood P
    BMJ; 2008 Nov; 337():a2581. PubMed ID: 19019864
    [No Abstract]   [Full Text] [Related]  

  • 59. POPADAD trial. Time for a proper study of aspirin after a vascular event?
    Cleland JG
    BMJ; 2008 Nov; 337():a2583. PubMed ID: 19019865
    [No Abstract]   [Full Text] [Related]  

  • 60. [Safety of specific cyclo-oxygenase 2 inhibitors].
    Verheugt FW
    Ned Tijdschr Geneeskd; 2001 Jul; 145(30):1478. PubMed ID: 11503323
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.